alexa Advance Diagnosis of Drug Resistance in Cancer: Towards Point-of-Care Electronic Nanodevice

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Advance Diagnosis of Drug Resistance in Cancer: Towards Point-of-Care Electronic Nanodevice

he development of multidrug resistance (MDR) in cancer cells is the main reason of cancer chemotherapy failure. Numerous mechanisms have been found which are responsible in the development of MDR in cancer cells [1]. The most important and well-studied factor responsible for is MDR, is a cell membrane transporter “permeability glycoprotein, (P-gp)” which is encoded by the MDR1 gene.

Citation: Chandra P (2015) Advance Diagnosis of Drug Resistance in Cancer: Towards Point-of-Care Electronic Nanodevice. J Anal Bioanal Tech 6: e120. doi: 10.4172/2155-9872.1000e120

 
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger
 
adwords